Seres Therapeutics: Q1 Earnings Snapshot

Published: 2026-05-05 07:15:13 ET MCRB

Published on 05/05/2026 at 07:15 am EDT

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Seres Therapeutics Inc. (MCRB) on Tuesday reported a loss of $19.9 million in its first quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $2.08.

The drug developer posted revenue of $358,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News